- Home
- IMMP
IMMP
Immutep Limited
as 11-26-2025 2:26pm EST
Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
| Founded: | 1987 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 256.1M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 128.2K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.32 - $2.71 | Next Earning Date: | 02-22-2026 |
| Revenue: | $3,306,742 | Revenue Growth: | 31.28% |
| Revenue Growth (this year): | -9.89% | Revenue Growth (next year): | N/A |
Latest Immutep Limited News
IMMP Breaking Stock News: Dive into IMMP Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 days ago
ASX Penny Stock Highlights: Immutep And 2 Other Noteworthy Picks
Simply Wall St.
10 days ago
Exploring High Growth Tech Stocks in Australia This November 2025
Simply Wall St.
13 days ago
ASX Stock Picks With Estimated Discounts Of Up To 39.1%
GlobeNewswire
14 days ago
Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025
Simply Wall St.
14 days ago
3 ASX Stocks That Could Be Trading Below Their Estimated Value In November 2025
Simply Wall St.
16 days ago
3 ASX Stocks That Could Be Trading At Discounts Of Up To 49.7%
Simply Wall St.
20 days ago
ASX Stocks That May Be Trading Below Estimated Value
Simply Wall St.
23 days ago
ASX Value Stocks Estimated Below Intrinsic Worth November 2025
Compare IMMP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IMMP Immutep Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.